Paul Tudor Jones Artivion, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Artivion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 143,964 shares of AORT stock, worth $3.84 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
143,964
Previous 68,804
109.24%
Holding current value
$3.84 Million
Previous $1.76 Million
117.23%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$177 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$74.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$74.6 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$73.3 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$65.4 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.08B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...